<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04536844</url>
  </required_header>
  <id_info>
    <org_study_id>33172</org_study_id>
    <nct_id>NCT04536844</nct_id>
  </id_info>
  <brief_title>Telehealth Follow-up in Patients With Rheumatoid Arthritis</brief_title>
  <official_title>Telehealth Follow-up in Patients With Rheumatoid Arthritis. A Noninferiority Randomized Control Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Martina Hansen's Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>London School of Economics and Political Science</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Helse Sor-Ost</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Martina Hansen's Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of the present project is to test the effect of a customized&#xD;
      Patient-Reported-Outcome (PRO)-based telehealth follow-up compared to a conventional&#xD;
      pre-scheduled outpatient follow-up to monitor disease activity and expenses associated with&#xD;
      the follow-up in patients with RA&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rheumatoid arthritis (RA) is a chronic inflammatory joint disease with a high burden both for&#xD;
      the patient and society. Outcomes for the individuals living with RA have been improved and&#xD;
      the majority of RA patients are now in remission or low disease activity status. RA patients&#xD;
      continue to be followed up by pre-scheduled visits, which may compromise accessibility for&#xD;
      the sickest and thus, quality of care. The introduction of patient-initiated follow-up leads&#xD;
      to a reduction in the use of outpatient clinic services without compromising outcomes.&#xD;
      Self-monitoring and remote patient monitoring are facilitated by electronic innovative health&#xD;
      tools. Among RA patients with low disease activity or remission, a Patient-Reported&#xD;
      Outcome-based telehealth follow-up for tight control of disease activity in RA can achieve&#xD;
      similar disease control as conventional outpatient follow-up and is likely to reduce the&#xD;
      costs. Thus, the main objective of the present project is to test the effect of a customized&#xD;
      PRO-based telehealth follow-up compared to a conventional prescheduled outpatient follow-up&#xD;
      to monitor disease activity and expenses associated with the follow-up in Norwegian RA&#xD;
      patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 15, 2020</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">August 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>This is a pragmatic noninferiority randomized controlled trial (RCT) in Norwegian RA patients in clinical remission (based on RAPID3 score). The patients will be allocated to 2 groups. One group will be followed up by an electronic app, while the second group will attend conventional prescheduled visits in the outpatient clinic of Martina Hansens Hospital. A computer-generated random number sequence will be used for the randomization of the RA patients.</intervention_model_description>
    <primary_purpose>Other</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients suffering a flare</measure>
    <time_frame>52 weeks</time_frame>
    <description>comparison of the number of patients suffering a flare in each group (Flare is defined as a routine assessment of patient index data 3 (RAPID3) score &gt;=3)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Satisfaction rates</measure>
    <time_frame>52 weeks</time_frame>
    <description>Compare satisfaction rates (as measured by Visual analog scale (VAS) satisfaction with the follow-up procedures) among the 2 patient groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Clinical disease activity index (CDAI)</measure>
    <time_frame>52 weeks</time_frame>
    <description>CDAI for both groups at baseline and at 52 weeks</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">220</enrollment>
  <condition>Rheumatoid Arthritis</condition>
  <condition>Treatment Compliance</condition>
  <arm_group>
    <arm_group_label>Telehealth follow-up group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Rheumatoid arthritis patients in remission who will be followed by an electronic app</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional follow-up group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Rheumatoid arthritis patients in remission who will attend conventional prescheduled visits in the outpatient clinic</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Mobile application MyDignio (follow disease activity by assigning questionnaires to participants)</intervention_name>
    <description>An electronic application available both on Apple store and Android play which the patients can download for free will be used to collect data from the Telehealth follow up group. This group will be compared to conventional outpatient clinic follow-up group.</description>
    <arm_group_label>Telehealth follow-up group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Conventional prescheduled follow-up</intervention_name>
    <description>Patients will be followed in the outpatient clinic by prescheduled follow-up</description>
    <arm_group_label>Conventional follow-up group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. &gt;18 years&#xD;
&#xD;
          2. Fulfilling the European League against Rheumatism (EULAR) / American College of&#xD;
             Rheumatology (ACR) 2010 classification criteria for RA&#xD;
&#xD;
          3. Being in remission (RAPID 3 score &lt;=3)&#xD;
&#xD;
          4. Able to use the electronic app&#xD;
&#xD;
          5. Able to give informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. &lt;18 years&#xD;
&#xD;
          2. Severe cognitive failure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Diamantopoulos, MD, PhD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Martina Hansens Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Martina Hansens Hospital</name>
      <address>
        <city>Sandvika</city>
        <state>Akershus</state>
        <zip>1337</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <reference>
    <citation>Cross M, Smith E, Hoy D, Carmona L, Wolfe F, Vos T, Williams B, Gabriel S, Lassere M, Johns N, Buchbinder R, Woolf A, March L. The global burden of rheumatoid arthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014 Jul;73(7):1316-22. doi: 10.1136/annrheumdis-2013-204627. Epub 2014 Feb 18.</citation>
    <PMID>24550173</PMID>
  </reference>
  <reference>
    <citation>McBain H, Shipley M, Olaleye A, Moore S, Newman S. A patient-initiated DMARD self-monitoring service for people with rheumatoid or psoriatic arthritis on methotrexate: a randomised controlled trial. Ann Rheum Dis. 2016 Jul;75(7):1343-9. doi: 10.1136/annrheumdis-2015-207768. Epub 2015 Aug 19.</citation>
    <PMID>26290587</PMID>
  </reference>
  <reference>
    <citation>Haugeberg G, Hansen IJ, Soldal DM, Sokka T. Ten years of change in clinical disease status and treatment in rheumatoid arthritis: results based on standardized monitoring of patients in an ordinary outpatient clinic in southern Norway. Arthritis Res Ther. 2015 Aug 20;17:219. doi: 10.1186/s13075-015-0716-0.</citation>
    <PMID>26290061</PMID>
  </reference>
  <reference>
    <citation>de Jong MJ, van der Meulen-de Jong AE, Romberg-Camps MJ, Becx MC, Maljaars JP, Cilissen M, van Bodegraven AA, Mahmmod N, Markus T, Hameeteman WM, Dijkstra G, Masclee AA, Boonen A, Winkens B, van Tubergen A, Jonkers DM, Pierik MJ. Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicentre, randomised controlled trial. Lancet. 2017 Sep 2;390(10098):959-968. doi: 10.1016/S0140-6736(17)31327-2. Epub 2017 Jul 14.</citation>
    <PMID>28716313</PMID>
  </reference>
  <reference>
    <citation>de Thurah A, Stengaard-Pedersen K, Axelsen M, Fredberg U, Schougaard LMV, Hjollund NHI, Pfeiffer-Jensen M, Laurberg TB, Tarp U, Lomborg K, Maribo T. Tele-Health Followup Strategy for Tight Control of Disease Activity in Rheumatoid Arthritis: Results of a Randomized Controlled Trial. Arthritis Care Res (Hoboken). 2018 Mar;70(3):353-360. doi: 10.1002/acr.23280. Epub 2018 Jan 23.</citation>
    <PMID>28511288</PMID>
  </reference>
  <reference>
    <citation>van Riel P, Alten R, Combe B, Abdulganieva D, Bousquet P, Courtenay M, Curiale C, Gómez-Centeno A, Haugeberg G, Leeb B, Puolakka K, Ravelli A, Rintelen B, Sarzi-Puttini P. Improving inflammatory arthritis management through tighter monitoring of patients and the use of innovative electronic tools. RMD Open. 2016 Nov 24;2(2):e000302. eCollection 2016. Review.</citation>
    <PMID>27933206</PMID>
  </reference>
  <reference>
    <citation>Pincus T, Yazici Y, Bergman M, Swearingen C, Harrington T. A proposed approach to recognise &quot;near-remission&quot; quantitatively without formal joint counts or laboratory tests: a patient self-report questionnaire routine assessment of patient index data (RAPID) score as a guide to a &quot;continuous quality improvement&quot; s. Clin Exp Rheumatol. 2006 Nov-Dec;24(6 Suppl 43):S-60-5; quiz S-66-73.</citation>
    <PMID>17083765</PMID>
  </reference>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>November 17, 2019</study_first_submitted>
  <study_first_submitted_qc>August 27, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">September 3, 2020</study_first_posted>
  <last_update_submitted>October 21, 2020</last_update_submitted>
  <last_update_submitted_qc>October 21, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Martina Hansen's Hospital</investigator_affiliation>
    <investigator_full_name>Anne Bull Haaversen</investigator_full_name>
    <investigator_title>Co-principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arthritis</mesh_term>
    <mesh_term>Arthritis, Rheumatoid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol and Statistical Analysis Plan</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>March 26, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/44/NCT04536844/Prot_SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

